benzyloxycarbonyl-phe-ala-fluormethylketone has been researched along with anacetrapib in 1 studies
| Studies (benzyloxycarbonyl-phe-ala-fluormethylketone) | Trials (benzyloxycarbonyl-phe-ala-fluormethylketone) | Recent Studies (post-2010) (benzyloxycarbonyl-phe-ala-fluormethylketone) | Studies (anacetrapib) | Trials (anacetrapib) | Recent Studies (post-2010) (anacetrapib) |
|---|---|---|---|---|---|
| 5 | 0 | 5 | 179 | 33 | 143 |
| Protein | Taxonomy | benzyloxycarbonyl-phe-ala-fluormethylketone (IC50) | anacetrapib (IC50) |
|---|---|---|---|
| Cholesteryl ester transfer protein | Homo sapiens (human) | 0.0343 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Johnson, BM; Meanwell, NA; Shu, YZ; Zhuo, X | 1 |
1 other study(ies) available for benzyloxycarbonyl-phe-ala-fluormethylketone and anacetrapib
| Article | Year |
|---|---|
Metabolic and Pharmaceutical Aspects of Fluorinated Compounds.
Topics: Drug Design; Fluorine; Halogenation; Humans; Pharmaceutical Preparations | 2020 |